---
title: "PepGen 提交了价值 4 亿美元的混合证券发行申请"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/286946645.md"
description: "2026 年 5 月 19 日东部夏令时间下午 12:23（MT Newswires）-- PepGen（PEPG）周一提交了一份注册声明，计划不时出售最多 4 亿美元的证券。该文件涵盖普通股和优先股、债务证券、认股权证和单位。公司表示，净收益将用于一般企业用途。价格：1.41，变动：-0.06，百分比变动：-4.08。MT Newswires 不提供投资建议。未经授权的复制是严格禁止的"
datetime: "2026-05-19T16:23:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286946645.md)
  - [en](https://longbridge.com/en/news/286946645.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286946645.md)
---

# PepGen 提交了价值 4 亿美元的混合证券发行申请

12:23 PM EDT, 05/19/2026 (MT Newswires) -- PepGen ( PEPG ) filed a registration statement Monday for the potential sale of up to $400 million of securities from time to time.

The filing covers common and preferred stocks, debt securities, warrants, and units.

Net proceeds will be used for general corporate purposes, the company said.

Price: 1.41, Change: -0.06, Percent Change: -4.08

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

### 相关股票

- [PEPG.US](https://longbridge.com/zh-CN/quote/PEPG.US.md)
- [PBE.US](https://longbridge.com/zh-CN/quote/PBE.US.md)
- [FBT.US](https://longbridge.com/zh-CN/quote/FBT.US.md)
- [BIB.US](https://longbridge.com/zh-CN/quote/BIB.US.md)
- [IBB.US](https://longbridge.com/zh-CN/quote/IBB.US.md)
- [SBIO.US](https://longbridge.com/zh-CN/quote/SBIO.US.md)
- [XBI.US](https://longbridge.com/zh-CN/quote/XBI.US.md)
- [BBH.US](https://longbridge.com/zh-CN/quote/BBH.US.md)
- [LABU.US](https://longbridge.com/zh-CN/quote/LABU.US.md)
- [ARKG.US](https://longbridge.com/zh-CN/quote/ARKG.US.md)
- [IBBQ.US](https://longbridge.com/zh-CN/quote/IBBQ.US.md)

## 相关资讯与研究

- [CAR-T 迎接新时代](https://longbridge.com/zh-CN/news/286999381.md)
- [创胜集团医药-B 合作伙伴 INHIBRX 报告 OZEKIBART 的 CRC 最新积极数据并宣布就治疗软骨肉瘤提交美国 BLA 申请](https://longbridge.com/zh-CN/news/287126678.md)
- [Tevogen Bio Q1 运营亏损收窄 48%，推进 AI 平台与细胞疗法管线](https://longbridge.com/zh-CN/news/287086570.md)
- [Scholar Rock 将出席杰富瑞全球医疗保健大会，聚焦 SMA 新药 apitegromab 关键审批](https://longbridge.com/zh-CN/news/287069556.md)
- [制药巨头集体拥抱 AI 智能体：百时美施贵宝向 3 万员工推广 Claude](https://longbridge.com/zh-CN/news/287074661.md)